News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
832,047 Results
Type
Article (85635)
Company Profile (744)
Press Release (745668)
Section
Business (232266)
Career Advice (4106)
Deals (39646)
Drug Delivery (117)
Drug Development (90667)
Employer Resources (194)
FDA (17980)
Job Trends (17274)
News (395610)
Policy (39623)
Tag
Academia (2975)
Alliances (56471)
Alzheimer's disease (1343)
Approvals (17889)
Artificial intelligence (161)
Bankruptcy (394)
Best Places to Work (12532)
Biotechnology (509)
Breast cancer (141)
Cancer (1213)
Cardiovascular disease (114)
Career advice (3513)
Cell therapy (275)
Clinical research (71593)
Collaboration (431)
Compensation (209)
COVID-19 (2805)
C-suite (108)
Data (1182)
Diabetes (170)
Diagnostics (6687)
Earnings (94766)
Employer resources (167)
Events (126925)
Executive appointments (335)
FDA (18562)
Funding (387)
Gene therapy (204)
GLP-1 (699)
Government (5049)
Healthcare (20724)
Infectious disease (2899)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17599)
Job creations (5179)
Job search strategy (2855)
Layoffs (490)
Legal (10044)
Lung cancer (191)
Manufacturing (204)
Medical device (14418)
Medtech (14423)
Mergers & acquisitions (22107)
Metabolic disorders (477)
Neuroscience (1655)
NextGen Class of 2024 (7657)
Non-profit (5065)
Northern California (1538)
Obesity (273)
Opinion (244)
Patents (115)
People (64209)
Pharmaceutical (148)
Phase I (22031)
Phase II (31090)
Phase III (23441)
Pipeline (476)
Postmarket research (3540)
Preclinical (9966)
Radiopharmaceuticals (259)
Rare diseases (250)
Real estate (7373)
Regulatory (25978)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1358)
Startups (4276)
United States (14855)
Vaccines (654)
Weight loss (222)
Date
Today (124)
Last 7 days (722)
Last 30 days (3946)
Last 365 days (38707)
2024 (35715)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (229)
Asia (49368)
Australia (8700)
California (3587)
Canada (1330)
China (270)
Colorado (161)
Connecticut (176)
Europe (113067)
Florida (484)
Georgia (132)
Illinois (425)
Indiana (217)
Kansas (103)
Maryland (637)
Massachusetts (2901)
Michigan (180)
Minnesota (301)
New Jersey (1026)
New York (1021)
North Carolina (851)
Northern California (1538)
Ohio (149)
Pennsylvania (881)
South America (1647)
Southern California (1358)
Texas (531)
Washington State (406)
There are 832,047 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
November 26, 2024
·
2 min read
·
Kate Goodwin
Layoff Tracker
BMS, Alector and Medigene Part Ways With Staff
Follow along as
BioSpace
keeps you up-to-date on the latest pharma and biotech layoffs.
November 26, 2024
·
191 min read
·
BioSpace Editorial Staff
Weight Loss
‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss
With Amgen’s MariTide results at the lower end of investors’ expectation of 20% to 25% weight loss, the much-anticipated readout sent the company’s shares tumbling.
November 26, 2024
·
2 min read
·
Annalee Armstrong
Drug shortages
Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability
Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.
November 26, 2024
·
4 min read
·
Ben Hargreaves
Mergers & acquisitions
Roche Buys Poseida for up to $1.5B, Leaning Into Off-the-Shelf CAR T
The acquisition announcement came alongside the reveal of a Phase III failure for Roche’s TIGIT asset tiragolumab, which when combined with Tecentriq did not significantly boost overall survival in non-small cell lung cancer.
November 26, 2024
·
3 min read
·
Tristan Manalac
Press Releases
BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer
November 26, 2024
·
7 min read
Press Releases
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
November 26, 2024
·
8 min read
Press Releases
Cognition Therapeutics Announces all Participants have Completed their Final Visits in the Phase 2 SHIMMER Study of CT1812 in Dementia with Lewy Bodies
November 26, 2024
·
7 min read
Press Releases
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
November 26, 2024
·
1 min read
Press Releases
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
November 26, 2024
·
1 min read
1 of 83,205
Next
